BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37340443)

  • 21. A Mettl16/m
    Han Y; Sun K; Yu S; Qin Y; Zhang Z; Luo J; Hu H; Dai L; Cui M; Jiang C; Liu F; Huang Y; Gao P; Chen X; Xin T; Ren X; Wu X; Song J; Wang Q; Tang Z; Chen J; Zhang H; Zhang X; Liu M; Luo D
    EMBO J; 2024 May; 43(10):1990-2014. PubMed ID: 38605226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
    Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
    J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
    Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
    Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.
    Yu H; Zhuang J; Zhou Z; Song Q; Lv J; Yang X; Yang H; Lu Q
    Int J Biol Sci; 2024; 20(4):1471-1491. PubMed ID: 38385084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
    Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
    Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
    Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
    Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
    Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
    BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of METTL16 as a cytoplasmic RNA binding protein.
    Nance DJ; Satterwhite ER; Bhaskar B; Misra S; Carraway KR; Mansfield KD
    PLoS One; 2020; 15(1):e0227647. PubMed ID: 31940410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis.
    Chen K; Zhang J; Meng L; Kong L; Lu M; Wang Z; Wang W
    J Exp Clin Cancer Res; 2024 Feb; 43(1):44. PubMed ID: 38326863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.
    Ye F; Wu J; Zhang F
    Biochem Biophys Res Commun; 2023 Jan; 638():1-6. PubMed ID: 36434904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells
    Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H
    Front Oncol; 2023; 13():1138238. PubMed ID: 37182151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis.
    Hu T; Liu H; Liang Z; Wang F; Zhou C; Zheng X; Zhang Y; Song Y; Hu J; He X; Xiao J; King RJ; Wu X; Lan P
    Theranostics; 2020; 10(9):4056-4072. PubMed ID: 32226539
    [No Abstract]   [Full Text] [Related]  

  • 36. N
    Li Z; Peng Y; Li J; Chen Z; Chen F; Tu J; Lin S; Wang H
    Nat Commun; 2020 May; 11(1):2578. PubMed ID: 32444598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
    Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
    Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
    Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
    Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL16 inhibits papillary thyroid cancer tumorigenicity through m
    Li Q; Wang Y; Meng X; Wang W; Duan F; Chen S; Zhang Y; Sheng Z; Gao Y; Zhou L
    Cell Mol Life Sci; 2024 Feb; 81(1):81. PubMed ID: 38334797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
    Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
    J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.